Published in Br J Haematol on June 01, 1995
Virus infection-associated improvement of platelet counts in chronic ITP. Br J Haematol (1995) 0.76
Virus infection-associated improvement of platelet counts in chronic ITP. Br J Haematol (1995) 0.75
Gammaherpesvirus latency induces antibody-associated thrombocytopenia in mice. J Autoimmun (2012) 0.75
Idiopathic thrombocytopenic purpura: a practice guideline developed by explicit methods for the American Society of Hematology. Blood (1996) 7.31
Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin. N Engl J Med (1995) 6.86
Extended use of nursing services in general practice. Br Med J (1967) 6.35
The practice nurse--a new look. Br Med J (1970) 5.16
Studies on the epidemiology of adverse drug reactions. V. Clinical factors influencing susceptibility. Ann Intern Med (1966) 5.11
Ligand binding to integrins. J Biol Chem (2000) 4.94
Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura. Canadian Apheresis Study Group. N Engl J Med (1991) 4.66
A multifactorial analysis of melanoma. IV. Prognostic factors in 200 melanoma patients with distant metastases (stage III). J Clin Oncol (1983) 3.80
Diagnosis of chlamydial infection in women attending antenatal and gynecologic clinics. J Clin Microbiol (1987) 3.70
Evaluation of pretest clinical score (4 T's) for the diagnosis of heparin-induced thrombocytopenia in two clinical settings. J Thromb Haemost (2006) 3.56
A novel vitronectin receptor integrin (alpha v beta x) is responsible for distinct adhesive properties of carcinoma cells. Cell (1989) 3.34
Reactions to tetanus toxoid. J Hyg (Lond) (1973) 3.33
Integrin activation controls metastasis in human breast cancer. Proc Natl Acad Sci U S A (2001) 3.07
Human lymphocytic metabolism. Effects of cyclic and noncyclic nucleotides on stimulation by phytohemagglutinin. J Clin Invest (1971) 3.01
Temporal aspects of heparin-induced thrombocytopenia. N Engl J Med (2001) 2.89
Impact of the patient population on the risk for heparin-induced thrombocytopenia. Blood (2000) 2.78
Local immune response in experimental pyelonephritis. J Clin Invest (1969) 2.73
Heparin and low-molecular-weight heparin: mechanisms of action, pharmacokinetics, dosing, monitoring, efficacy, and safety. Chest (2001) 2.72
Localization of urinary-tract infections by detection of antibody-coated bacteria in urine sediment. N Engl J Med (1974) 2.63
Cultivation of Pneumocystis carinii with WI-38 cells. J Clin Microbiol (1979) 2.63
Eikenella corrodens, a recently recognized pathogen: infections in medical-surgical patients and in association with methylphenidate abuse. Medicine (Baltimore) (1974) 2.61
Cyclic adenosine 3',5'-monophosphate in human lymphocytes. Alterations after phytohemagglutinin stimulation. J Clin Invest (1971) 2.61
Rapid anticoagulation using ancrod for heparin-induced thrombocytopenia. Blood (1991) 2.54
Severe bleeding events in adults and children with primary immune thrombocytopenia: a systematic review. J Thromb Haemost (2015) 2.46
Alterations in cyclic adenosine monophosphate metabolism in human bronchial asthma. I. Leukocyte responsiveness to -adrenergic agents. J Clin Invest (1973) 2.42
RED: a red-cell antibody identification expert module. J Med Syst (1985) 2.24
General practitioners in hospital. Br Med J (1970) 2.22
New rat model of Pneumocystis carinii infection. J Clin Microbiol (1988) 2.21
Excess mortality associated with influenza in England and Wales. Int J Epidemiol (1977) 2.20
Current therapy for cutaneous melanoma. J Am Acad Dermatol (1995) 2.19
A prospective study to determine the safety of omitting the antiglobulin crossmatch from pretransfusion testing. Br J Haematol (1992) 2.18
Frequency of immediate adverse effects associated with therapeutic apheresis. Transfusion (1999) 2.17
Typing of Pneumocystis carinii strains that infect humans based on nucleotide sequence variations of internal transcribed spacers of rRNA genes. J Clin Microbiol (1994) 2.17
MT1-MMP initiates activation of pro-MMP-2 and integrin alphavbeta3 promotes maturation of MMP-2 in breast carcinoma cells. Exp Cell Res (2001) 2.12
Excess deaths attributable to influenza in England and Wales: age at death and certified cause. Int J Epidemiol (1983) 2.12
Update on Pneumocystis carinii f. sp. hominis typing based on nucleotide sequence variations in internal transcribed spacer regions of rRNA genes. J Clin Microbiol (1998) 2.11
The role of the plasma from platelet concentrates in transfusion reactions. N Engl J Med (1994) 2.09
Nucleotide sequence variation in Pneumocystis carinii strains that infect humans. J Clin Microbiol (1993) 2.08
Fetal thrombocytopenia and its relation to maternal thrombocytopenia. N Engl J Med (1993) 2.08
The vitronectin receptor alpha v beta 3 binds fibronectin and acts in concert with alpha 5 beta 1 in promoting cellular attachment and spreading on fibronectin. J Cell Biol (1990) 2.07
High-dose intravenous immune globulin and the response to splenectomy in patients with idiopathic thrombocytopenic purpura. N Engl J Med (1997) 2.05
Duration of immunity after active immunisation against tetanus. Lancet (1969) 2.04
A 14-year study of heparin-induced thrombocytopenia. Am J Med (1996) 2.03
A prospective study to determine the frequency and clinical significance of alloimmunization post-transfusion. Br J Haematol (1995) 2.01
The pathogenesis of venous limb gangrene associated with heparin-induced thrombocytopenia. Ann Intern Med (1997) 2.00
Progressive disseminated histoplasmosis. A prospective study of 26 patients. Ann Intern Med (1972) 1.99
Radioimmunoassay for prostaglandins. Science (1971) 1.99
Primary sarcomas of the mediastinum: results of therapy. J Thorac Cardiovasc Surg (1998) 1.96
Immune interactions with cells infected with herpes simplex virus: antibodies to radioiodinated surface antigens. J Immunol (1977) 1.94
The influence of a competitor on the geographic mosaic of coevolution between crossbills and lodgepole pine. Evolution (2001) 1.93
Antimicrobial susceptibility of Pneumocystis carinii in culture. Diagn Microbiol Infect Dis (1985) 1.78
The effect of iron deficiency on the levels of hemoglobins A2 and E. J Lab Clin Med (1968) 1.76
Quantitative interpretation of optical density measurements using PF4-dependent enzyme-immunoassays. J Thromb Haemost (2008) 1.75
Early-onset and persisting thrombocytopenia in post-cardiac surgery patients is rarely due to heparin-induced thrombocytopenia, even when antibody tests are positive. J Thromb Haemost (2009) 1.73
THE CATEGORY OF TOPOLOGICAL OBJECTS. Proc Natl Acad Sci U S A (1961) 1.73
Activity of lipid-soluble inhibitors of dihydrofolate reductase against Pneumocystis carinii in culture and in a rat model of infection. Antimicrob Agents Chemother (1987) 1.72
Alcohol and other substance abuse and impairment among physicians in residency training. Ann Intern Med (1992) 1.72
Alpha- and beta-thalassemia in Thailand. Ann N Y Acad Sci (1969) 1.72
Prevention of tetanus in the wounded. Br Med J (1975) 1.71
Observations on the collagen and proteinpolysaccharide complex of rabbit cornea stroma. J Cell Sci (1969) 1.70
HIV transmitted by sexual intercourse but not by kissing. Br Med J (Clin Res Ed) (1987) 1.70
Prevalence and clinical correlates of pulmonary arterial hypertension in progressive systemic sclerosis. Am J Med (1983) 1.70
Use of the 51 Cr release test to demonstrate patterns of antibody response in humans to herpesvirus types 1 and 2. J Immunol (1972) 1.68
Comparative study of district and community hospitals. Br Med J (1973) 1.67
Heparin and low-molecular-weight heparin: mechanisms of action, pharmacokinetics, dosing considerations, monitoring, efficacy, and safety. Chest (1998) 1.67
Integrin-mediated cell adhesion: the extracellular face. J Biol Chem (1994) 1.66
Activity of clindamycin with primaquine against Pneumocystis carinii in vitro and in vivo. Antimicrob Agents Chemother (1988) 1.64
Argatroban anticoagulant therapy in patients with heparin-induced thrombocytopenia. Circulation (2001) 1.64
Growth and toxin production of Tetanus bacilli in vivo. J Med Microbiol (1974) 1.63
Pneumocystis carinii: improved models to study efficacy of drugs for treatment or prophylaxis of Pneumocystis pneumonia in the rat (Rattus spp.). Exp Parasitol (1990) 1.61
Risk of infection after penetrating abdominal trauma. N Engl J Med (1984) 1.60
Dihydropteroate synthase polymorphisms in Pneumocystis carinii. J Infect Dis (1997) 1.60
Identification of a novel integrin binding site in fibronectin. Differential utilization by beta 3 integrins. J Biol Chem (1994) 1.60
The RADAR repository: a resource for studies of infectious agents and their transmissibility by transfusion. Transfusion (2005) 1.60
Excess morbidity and mortality associated with influenza in England and Wales. Lancet (1980) 1.57
Functional activation of integrin alpha V beta 3 in tumor cells expressing membrane-type 1 matrix metalloproteinase. Int J Cancer (2000) 1.56
Histoplasmosis in immunosuppressed patients. Am J Med (1978) 1.54
Observations on the distribution of the proteinpolysaccharide complex and collagen in bovine articular cartilage. J Cell Sci (1967) 1.54
Substrate hydrolysis by matrix metalloproteinase-9. J Biol Chem (2001) 1.54
The pattern of disordered haemoglobin synthesis in homozygous and heterozygous beta-thalassaemia. Br J Haematol (1969) 1.54
Clinical evaluation of intraperitoneal Pseudomonas exotoxin immunoconjugate OVB3-PE in patients with ovarian cancer. J Clin Oncol (1991) 1.53
Observations on the morphology of the proteinpolysaccharide complex of bovine nasal cartilage and its relationship to collagen. Proc R Soc Lond B Biol Sci (1966) 1.53
The beta-tubulin gene from rat and human isolates of Pneumocystis carinii. Mol Microbiol (1992) 1.52
Haemoglobin synthesis in beta-thalassaemia. Nature (1968) 1.52
Detection of Pneumocystis carinii DNA in air samples: likely environmental risk to susceptible persons. J Clin Microbiol (1997) 1.52
A prospective study to identify the risk factors associated with acute reactions to platelet and red cell transfusions. Transfusion (1993) 1.52
Activation of platelets by sera containing IgG1 heparin-dependent antibodies: an explanation for the predominance of the Fc gammaRIIa "low responder" (his131) gene in patients with heparin-induced thrombocytopenia. J Lab Clin Med (1997) 1.51
Mechanism of integrin activation by disulfide bond reduction. Biochemistry (2001) 1.51
Prevalence and clinical features of HTLV neurologic disease in the HTLV Outcomes Study. Neurology (2003) 1.51
Frequency of immediate adverse effects associated with apheresis donation. Transfusion (1998) 1.49
Experimental abortion and the systemic immune response to "Haemophilus somnus" in cattle. Infect Immun (1986) 1.48
Splenectomy done during hematologic remission to prevent relapse in patients with thrombotic thrombocytopenic purpura. Ann Intern Med (1996) 1.48
Comparative evaluation of a modified zinc sulfate flotation technique. J Clin Microbiol (1978) 1.48
Pneumocystis carinii, an opportunist in immunocompromised patients. Clin Microbiol Rev (1991) 1.47
A biochemical characterization of the binding of osteopontin to integrins alpha v beta 1 and alpha v beta 5. J Biol Chem (1995) 1.47